KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Incyte (INCY) over the last 15 years, with Sep 2025 value amounting to $86.8 million.

  • Incyte's Other Operating Expenses fell 20.66% to $86.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.3 million, marking a year-over-year decrease of 65.50%. This contributed to the annual value of $330.8 million for FY2024, which is 15.58% up from last year.
  • As of Q3 2025, Incyte's Other Operating Expenses stood at $86.8 million, which was up 161.68% from -$140.7 million recorded in Q2 2025.
  • Incyte's Other Operating Expenses' 5-year high stood at $109.4 million during Q3 2024, with a 5-year trough of -$140.7 million in Q2 2025.
  • Moreover, its 3-year median value for Other Operating Expenses was $77.5 million (2024), whereas its average is $58.9 million.
  • As far as peak fluctuations go, Incyte's Other Operating Expenses soared by 80.18% in 2024, and later tumbled by 281.52% in 2025.
  • Quarterly analysis of 5 years shows Incyte's Other Operating Expenses stood at $53.1 million in 2021, then surged by 55.26% to $82.4 million in 2022, then increased by 6.41% to $87.7 million in 2023, then dropped by 3.73% to $84.4 million in 2024, then declined by 20.66% to $86.8 million in 2025.
  • Its Other Operating Expenses stands at $86.8 million for Q3 2025, versus -$140.7 million for Q2 2025 and $84.8 million for Q1 2025.